Assessing Putative Markers of Colorectal Cancer Stem Cells: From Colonoscopy to Gene Expression Profiling.
Saved in:
| Title: | Assessing Putative Markers of Colorectal Cancer Stem Cells: From Colonoscopy to Gene Expression Profiling. |
|---|---|
| Authors: | Harbiyeli IFC; Research Center of Gastroenterology and Hepatology Craiova, University of Medicine and Pharmacy Craiova, 200349 Craiova, Romania., Burtea DE; Research Center of Gastroenterology and Hepatology Craiova, University of Medicine and Pharmacy Craiova, 200349 Craiova, Romania., Ivan ET; Research Center of Gastroenterology and Hepatology Craiova, University of Medicine and Pharmacy Craiova, 200349 Craiova, Romania., Streață I; Human Genomics Laboratory, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania., Nicoli ER; Human Genomics Laboratory, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania., Uscatu D; Human Genomics Laboratory, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania., Șerbănescu MS; Department of Medical Informatics and Biostatistics, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania., Ioana M; Human Genomics Laboratory, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania., Vilmann P; Gastro Unit, Division of Endoscopy, Copenhagen University Hospital Herlev, 2730 Herlev, Denmark., Săftoiu A; Research Center of Gastroenterology and Hepatology Craiova, University of Medicine and Pharmacy Craiova, 200349 Craiova, Romania. |
| Source: | Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2022 Sep 21; Vol. 12 (10). Date of Electronic Publication: 2022 Sep 21. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101658402 Publication Model: Electronic Cited Medium: Print ISSN: 2075-4418 (Print) Linking ISSN: 20754418 NLM ISO Abbreviation: Diagnostics (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
